Mereo BioPharma Group Statistics

Total Valuation

MREO has a market cap or net worth of $441.46 million. The enterprise value is $367.62 million.

Market Cap	441.46M
Enterprise Value	367.62M

Important Dates

The next estimated earnings date is Wednesday, March 26, 2025, after market close.

Earnings Date	Mar 26, 2025
Ex-Dividend Date	n/a

Share Statistics

MREO has 154.90 million shares outstanding. The number of shares has increased by 12.61% in one year.

Current Share Class	n/a
Shares Outstanding	154.90M
Shares Change (YoY)	+12.61%
Shares Change (QoQ)	+8.20%
Owned by Insiders (%)	3.27%
Owned by Institutions (%)	47.26%
Float	101.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	441.46
Forward PS	n/a
PB Ratio	6.07
P/TBV Ratio	6.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	367.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.09.

Current Ratio	6.10
Quick Ratio	5.83
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28.24

Financial Efficiency

Return on equity (ROE) is -62.11% and return on invested capital (ROIC) is -28.94%.

Return on Equity (ROE)	-62.11%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-28.94%
Return on Capital Employed (ROCE)	-51.07%
Revenue Per Employee	$30,303
Profits Per Employee	-$1.37M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-532,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.39% in the last 52 weeks. The beta is 0.85, so MREO's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	-20.39%
50-Day Moving Average	3.26
200-Day Moving Average	3.76
Relative Strength Index (RSI)	38.17
Average Volume (20 Days)	882,209

Short Selling Information

Short Interest	6.82M
Short Previous Month	7.20M
Short % of Shares Out	3.98%
Short % of Float	n/a
Short Ratio (days to cover)	6.58

Income Statement

In the last 12 months, MREO had revenue of $1.00 million and -$45.32 million in losses. Loss per share was -$0.31.

Revenue	1.00M
Gross Profit	1.27M
Operating Income	-38.07M
Pretax Income	n/a
Net Income	-45.32M
EBITDA	-37.48M
EBIT	-38.07M
Loss Per Share	-$0.31

Full Income Statement

Balance Sheet

The company has $80.52 million in cash and $6.68 million in debt, giving a net cash position of $73.84 million or $0.48 per share.

Cash & Cash Equivalents	80.52M
Total Debt	6.68M
Net Cash	73.84M
Net Cash Per Share	$0.48
Equity (Book Value)	72.54M
Book Value Per Share	0.47
Working Capital	72.52M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-30.20M
Capital Expenditures	n/a
Free Cash Flow	-30.20M
FCF Per Share	-$0.19

Full Cash Flow Statement

Margins

Gross Margin	127.30%
Operating Margin	-3,806.60%
Pretax Margin	-4,584.80%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MREO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.61%
Shareholder Yield	-12.61%
Earnings Yield	-10.27%
FCF Yield	-6.84%

Analyst Forecast

The average price target for MREO is $7.83, which is 174.74% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.83
Price Target Difference	174.74%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	80.96%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MREO has an Altman Z-Score of 9.32 and a Piotroski F-Score of 2.

Altman Z-Score	9.32
Piotroski F-Score	2